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Abstract
Background—The impact of Roux-en-Y gastric bypass (RYGB) on type 2 diabetes mellitus is 
thought to result from upper and/or lower gut hormone alterations. Evidence supporting these 
mechanisms is incomplete, in part because of limitations in relevant bariatric-surgery animal 
models, specifically the lack of naturally insulin-resistant large animals. With overfeeding, 
Ossabaw swine develop a robust metabolic syndrome, and may be suitable for studying post-
surgical physiology. Whether bariatric surgery is feasible in these animals with acceptable survival 
is unknown.
Methods—Thirty-two Ossabaws were fed a high-fat, high-cholesterol diet to induce obesity and 
insulin resistance. These animals were assigned to RYGB (n = 8), RYGB with vagotomy (RYGB-
V, n = 5), gastrojejunostomy (GJ, n = 10), GJ with duodenal exclusion (GJD, n = 7), or sham 
operation (n = 2) and were euthanized 60 days post-operatively. Post-operative changes in weight 
and food intake are reported.
Results—Survival to scheduled necropsy among surgical groups was 77%, living an average of 
57 days post-operatively. Cardiac arrest under anesthesia occurred in 4 pigs. Greatest weight loss 
(18.0% ± 6%) and food intake decrease (57.0% ± 20%) occurred following RYGB while animals 
undergoing RYGB-V showed only 6.6% ± 3% weight loss despite 50.8% ± 25% food intake 
decrease. GJ (12.7% ± 4%) and GJD (1.2% ± 1%) pigs gained weight, but less than sham controls 
(13.4% ± 10%).
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Conclusions—A survival model of metabolic surgical procedures is feasible, leads to significant 
weight loss, and provides the opportunity to evaluate new interventions and subtle variations in 
surgical technique (e.g. vagus nerve sparing) that may provide new mechanistic insights.
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1. Introduction
Roux-en-Y gastric bypass surgery (RYGB) promotes substantial, sustained weight loss [1] 
[2], and it is the most effective method to ameliorate obesity-related comorbidity including 
type 2 diabetes mellitus (T2DM) [3]-[5]. Because major improvements in T2DM typically 
occur prior and out of proportion to significant body weight loss [6], the impact of RYGB on 
T2DM may not result from weight loss and reduced caloric intake alone. Important 
unanswered questions regarding the anti-diabetes effects of RYGB remain, including 
contributions of the proximal vs. distal intestines in T2DM remission, the reversibility of 
improved glycemic control with foregut exposure to food, and roles of the vagus nerve in 
these effects.
Over the past several years, our group has developed a porcine survival model for metabolic 
surgery [7] and more recently extended that work to address one of the major shortcomings 
of large animals as models for metabolic surgery. Over many generations, animal husbandry 
practices have limited the gene pool of large animals such that there are no natural models of 
“unhealthy” obesity. Farm animals rendered obese typically do not develop insulin 
resistance or heart disease, and consequently, large animal models of metabolic disease have 
been limited [8]. Classically, larger animals are given toxins (e.g. streptozotocin) to impair 
pancreatic function [9], while small animal models depend on knockout or gene silencing 
techniques to mimic human insulin resistance.
Although a naturally occurring large animal model of diabetes does not exist, in the 1970s, 
on Ossabaw Island near Georgia, a colony of pigs was discovered that exhibited many 
features useful for the study of bariatric surgery. Abundant natural resources exist on the 
island only seasonally, followed by periods of food scarcity. Through generations of natural 
selection, surviving Ossabaw pigs gain large amounts of weight during times of plenty, 
allowing them to survive seasonal famines. Exhibiting “thrifty genome” characteristics when 
provided unrestricted access to high-calorie diets [10]-[12], they develop obesity, insulin 
resistance and glucose intolerance [13], dyslipidemia [14] [15], and hypertension [14] [16], 
which are widely accepted characteristics of metabolic syndrome (MetS) [16]-[18].
The objective of this study was to determine the feasibility and appropriateness of bariatric 
surgical techniques in the Ossabaw survival model. The advantages of a large-animal model 
are its similarities with humans regarding techniques and anatomic features. More so than 
rodents, the upper GI tract is very similar in humans and pigs [19], and allows application of 
nearly identical surgical techniques and instruments. In obese Ossabaw pigs, we describe our 
initial experience with long-term survival surgery including RYGB without vagotomy, 
RYGB with vagotomy (RYGB-V), gastrojejunostomy with duodenal exclusion (GJD, which 
Simianu et al. Page 2
Surg Sci. Author manuscript; available in PMC 2016 May 18.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
creates a gastric-sparing bypass of the segment of proximal intestine excluded in RYGB), 
and gastrojejunostomy (GJ, which is identical to the latter operation with duodenal 
inclusion). These variations were selected to better elucidate what had been dubbed the 
upper and lower intestinal hypotheses for endocrine/metabolic pathways of diabetes 
development and resolution.
2. Materials and Methods
All experimental procedures involving animals were approved by the Institutional Animal 
Care and Use Committee at the University of Washington (UW) with the recommendations 
outlined by the National Research Council and the American Veterinary Medical 
Association Panel on Euthanasia [20] [21].
2.1. Animals and Environment
Since January 2010, 32 female Ossabaw swine have entered the study protocol. Pigs were 
obtained from the joint Indiana University School of Medicine (IUSM) and Purdue 
University Facility. This study excludes 1 pig which died at IUSM before shipment. To 
promote weight gain and insulin resistance, animals were maintained on excess calorie high-
fat, high-cholesterol diet (vide infra) for ≥180 days before arriving at UW, at age 12 - 18 
months. Pigs were acclimated to the UW research facility for at least 7 days before 
undergoing initial vascular access catheter placement. Animals lived in a 70°F temperature-
controlled room on a 12:12-h light:dark cycle. They had free access to drinking water and 
were removed at least once daily for stall cleaning. Experimental pigs were fed twice daily 
at fixed times a customized obesogenic TestDiet® containing high levels of fructose, lipids, 
and cholesterol, with 16.1% proteins, 43.1% lipids, and 40.8% carbohydrates (3580 kcal/
meal or 7160 kcal/day).
Twenty Ossabaw were fed standard, non-fat chow (~3000 kcal/day) and served as non-
surgical, lean controls. Food intake was recorded daily. Change in food intake was derived 
from food volume left uneaten, measured at daily feeding times, and calculated as difference 
from preoperative baseline.
2.2. Intravascular Catheters
All animals were surgically implanted with vascular-access catheters to permit collection of 
serial blood samples and for medication administration (e.g., analgesics, antibiotics if 
necessary) postoperatively. Porcine animal models pose a special challenge for long-term 
vascular access given their size and lack of physical restraint [22]-[24]. Catheters were 
initially placed in the external jugular vein percutaneously, but early problems with this 
technique led us to switch to tunneled placement in the internal jugular vein under 
anesthesia. All tunneled placements used 12 Fr. Dual lumen Hickman Catheter (Bard 
Peripheral Vascular, Tempe, AZ) using a technique that has previously been described [25] 
[26]. Catheter replacements were required whenever catheters malfunctioned. Early in the 
study period, catheters were removed at 2 weeks post-operatively and replaced close to 60 
days post-operatively, prior to necropsy. Following several anesthesia-related deaths, 
however, pigs in the later part of the study maintained catheters throughout the entire 
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experimental period. Catheters were flushed at least twice daily with a heparin-saline 
solution then locked with a solution containing vancomycin (1.0 mg/ml).
2.3. Surgical Intervention
Pigs were randomly assigned to one of four GI operations (RYGB, RYGB-V, GJ, GJD) or a 
sham operation. All operations were standardized, and our pre-operative and anesthesia 
protocols have been previously reported [7]. For RYGB, a gastric pouch approximately 3 × 3 
cm was created. The small bowel reconstruction approximated the human RYGB with 
approximately ~45 cm of biliary-pancreatic-duodenal (BPD) limb. However, given 
recognized variation in the intestinal length of Ossabawswine [19], the entire small bowel 
length was measured in each animal and one third of the small bowel used for an antecolic, 
antegastric alimentary limb. The RYGB-V is identical, but includes division of anterior and 
posterior vagus nerves as they cross the gastro-esophageal junction. Resection of nervous 
tissue was confirmed by histologic assessment. The GJ operation creates a connection 
between the mid-stomach and jejunum (as with RYGB procedures approximately one third 
of the distance on the small bowel), with full preservation of the stomach and pylorus. The 
GJD operation is similar to GJ, with additional division and detachment of the pylorus from 
the proximal duodenum, bypassing the same length of small bowel as in RYGB and RYGB-
V. Sham surgery involves a full midline incision and bowel manipulation for ~130 minutes, 
the time of an average RYGB.
Early in the study, gastro-enteric anastomoses were performed using 4.5-mm GIA (United 
States Surgical, Norwalk, CT) stapler around the anvil of a 25-mm circular stapler. However, 
the thickened esophageal and gastric walls resulted in early anastomotic dehiscence at the 
esophageal-gastric junction, resulting in mediastinitis and/or peritonitis, and ultimately in 
untimely death in 5 animals. After these complications, we revised our protocol to hand-
sewing for the gastric-jejunostomy anastomoses, and we created better practices for 
monitoring post-surgical outcomes to identify dehiscence within the first few post-operative 
days, using endoscopic exploration when animals began to deteriorate clinically. We 
continued to perform the side-to-side jejuno-jejunosto-my using a GIA stapler and 3-0 
Maxon (United States Surgical, Norwalk, CT) reinforcement suture as we have previously 
described [7].
2.4. Statistical Analyses
Data analyses were descriptive rather than comparative, given the small number of animals 
involved. Pre-operative weights are reported as means with standard deviations (SD). Weight 
change is reported as a percentage change (±SD) using difference between pre-operative and 
pre-necropsy weights. Food intake change is reported as a percentage change (±SD) using 
average daily intake before and serially after surgery. Excel (version 12.3.6, Microsoft) was 
used for statistical analysis.
3. Results
Thirty-two Ossabaw swine have been studied to date, and survival and detailed perioperative 
complications are reported in Table 1. Six out of 8 (75%) pigs assigned to RYGB survived to 
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scheduled necropsy. One that died post-operatively was euthanized on POD 35 after 
evisceration; necropsy revealed intra-abdominal adhesions but an intact anastomosis. The 
other died on POD 63, with necropsy showing severe necro-hemorrhagic enteritis and 
typhlocolitis, presumably from Clostridium difficile infection. Five pigs were assigned to 
RYGB-V. One had cardiac arrest during surgery and was not counted towards the overall 
survival. Two died before scheduled necropsy. One was re-explored on POD7 for 
anastomotic leak, and died during surgery. The other underwent revision of a laparotomy 
closure on POD2 and was subsequently euthanized on POD 11 from RYGB-V due to failure 
to thrive and PO intolerance. Necropsy revealed an intact but edematous gastro-jejunostomy.
Ten pigs were assigned to GJ surgery, with 8 of the 9 (89%) who underwent the operation 
surviving to scheduled necropsy. One pig died in the recovery phase of initial catheter 
placement and never underwent GJ, and was not counted towards the overall survival of the 
group. Another went into cardiac arrest during tunneled catheter replacement on POD 57; 
necropsy revealed pulmonary changes consistent with cardiac arrest. Seven pigs underwent 
GJD, and 6 (86%) survived to scheduled necropsy. One died on POD5; necropsy revealed 
pancreatitis. Two pigs underwent sham surgery, with only one surviving to scheduled 
necropsy. The other died on POD 75 from cardiac arrest during attempted tunneled catheter 
replacement.
The mean preoperative weight of high-fat-fed Ossabaws was 73.4 ± 8.6 kg compared to 63.2 
± 12.9 kg in chow-fed Ossabaws. Preoperative weights for each surgical procedure were: 
Sham 78.1 ± 15.2 kg; GJ 72.3 ± 8.0 kg; GJD 79.8 ± 8.1 kg; RYGB 68.5 ± 7.0 kg; and 
RYGB-V 70.7 ± 6.7 kg. Postoperative weight and food intake change, stratified by 
operation, are shown in Figure 1 and Figure 2, respectively. Ossabaws undergoing sham 
operation gained 13.4% ± 9.5% weight and increased their food intake by 7.3% ± 5.2% over 
the experimental period. Over an equivalent period, GJ pigs gained 12.7% ± 4.2% weight 
and increased food intake by 2.1% ± 0.7%. Pigs in the GJD group gained 1.2% ± 0.5% 
weight but decreased their food intake by 15.6% ± 5.9%. Pigs in the RYGB and RYGB-V 
groups decreased their weight by 18.0% ± 6.4% and 6.6% ± 3.3% respectively, and 
decreased their food intake by 57.0% ± 20.2% and 50.8% ± 25.4%.
4. Discussion
Surgical approaches to obesity consistently promote major, sustained weight loss, and 
improvement or remission of many, obesity-related comorbidities. This reduction in 
comorbidities, most notably T2DM, cannot be explained solely by the effects of weight loss 
and reduced caloric intake, and there are several hypotheses regarding how GI 
rearrangement ameliorates diabetes [6] [27]. The “upper intestinal hypothesis” postulates 
that exclusion of the proximal small bowel from ingested nutrients exerts direct anti-diabetes 
effects, potentially through incompletely identified, nutrient-regulated factors or processes 
that influence glucose homeostasis [28] [29]. The “lower intestinal hypothesis” postulates 
that enhanced delivery of nutrients to the distal bowel augments glucagon-like peptide-1 
secretion, increasing insulin secretion [30] [31]. In addition, compromised secretion of the 
pro-diabetic hormone ghrelin after RYGB might help improve glucose tolerance [32] [33]. 
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Unfortunately, surgical experimental GI manipulations to test these hypotheses are often not 
practical in humans [34].
Rodents are the dominant model for metabolic surgical evaluations [19], but concerns over 
anatomic differences and variation in physiologic responses compared with humans limit 
their utility in studying feasibility of surgical techniques [35]. Insulin resistance in obese, 
large animals amenable to routine biomedical study has heretofore been lacking. Although 
swine appear to be a more appropriate model to study bariatric surgical changes because of 
their anatomic and functional GI similarity to humans [36] [37], as well as their equivalent 
hormonal responses to starvation and feeding [38]-[40], the lack of a swine model with 
insulin resistance has been problematic [8].
The Ossabaw miniature swine appears to have a form of naturally occurring, polygenic 
insulin resistance, along with a unique propensity to obesity [10]-[13] and dyslipidemia [14] 
[15]. Comparisons of Ossabaw swine to the well-established Yucatan swine model revealed 
that Ossabaws show greater propensity to obesity, especially visceral, than Yucatans on 
rigorously controlled experimental diets [14]-[17]. The miniature stature of Ossabaw pigs 
(50 - 70 kg at six months), coupled with metabolic-syndrome characteristics at this age, 
make them an ideal animal model for metabolic biomedical research. Having performed 
RYGB in other swine breeds [7], we hypothesized that the Ossabaw would be a superior 
model for studies of metabolic surgery and glucose homeostasis. Our investigations confirm 
that high-fat-fed Ossabaws had higher pre-operative weights compared to lean Ossabaws. In 
addition, evidence of increased levels of fasting glucose, insulin, and insulin resistance in 
these animals and the impact of the GI surgeries on glucose homeostasis, have been 
separately reported by our group [41].
The surgical survival model we developed is feasible and effective, but required trial and 
error manipulations, especially related to repeated anesthesia exposure. Although not all 
animals survived to necropsy, an important marker of a successful model is the ability to 
reproducibly perform “human-like” procedures and techniques and sustain enough animals 
to target survival dates. Three deaths occurred late in the study period from non-surgical 
causes, approximately at or beyond 60 days. We achieved 77% survival to scheduled 
necropsy, with intra-operative cardiac arrest being the leading cause of premature death. 
Three of the animals died during catheter placements, with two deaths from catheter 
replacement prior to scheduled necropsy. Two animals required re-exploration, and one died 
of intra-operative hemorrhage. These anesthesia complications were early in the model 
development (first 10 cases) and prompted important changes in our protocol to minimize 
anesthesia exposure. Only 3 unplanned deaths occurred during the second 22 cases (86% 
survival).
Our GI operations were designed to clarify mechanisms involved in bariatric post-surgical 
changes. As expected, our sham operation served as a control and did not lead to a decrease 
in weight or food intake. The GJ operation creates a moderate shortcut for food to pass from 
the intact stomach into the proximal jejunum, equivalent to the intestinal shortcut in our 
porcine RYGB but without gastric restriction or proximal intestinal bypass. By expediting 
delivery of ingested nutrients to the distal bowel, the operation discretely engages 
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physiologic phenomena described in the lower intestinal hypothesis, but only to a degree of 
RYGB. In our study, the GJ did not inhibit weight gain, and the pigs had only a slight 
increase in food intake. These animals could serve in future, more sophisticated studies of 
glucose homeostasis to explore the distal intestinal hypothesis without confounding from 
weight loss.
The GJD procedure creates the same shortcut from stomach to jejunum as does GJ and 
RYGB, but unlike GJ, it excludes proximal intestinal nutrient exposure similar to a 
traditional RYGB. Comparing the effects of GJD vs. GJ on glucose homeostasis will allow 
us to distinguish discrete consequences of phenomena described in the upper and lower 
intestinal hypotheses. Neither of these procedures is confounded by any added gastric 
alterations, nor do they cause weight loss in our pigs. We have previously reported how these 
operations should highlight the weight-independent effects of distal intestinal nutrient 
exposure vs. proximal intestinal nutrient exclusion on glucose homeostasis [41], and studies 
describing hormonal alterations in these pigs are underway by our group.
Along with the upper and lower intestinal pathways influenced by the GJ and GJD 
operations, RYGB reduces gastric capacity. By comparing this operation with the other two, 
we can discriminate effects on glucose homeostasis that are related to gastric change and/or 
weight loss from those that result purely from the upper and lower intestinal hypotheses. The 
role of the vagus nerve in glucose homeostasis can be studied with the RYGB-V operation. 
The GI tract is heavily innervated by the vagus, which mediates many effects of gut peptides 
on satiety and glucose homeostasis [42] [43]. Hence, vagotomy might be expected to 
promote increased meal size and weight gain. This very preliminary data would hint that 
vagotomy attenuates the effects of RYGB on weight loss, without a major effect on food 
intake. These conclusions are limited by the small numbers and high mortality in our 
RYGB-V group and require further study.
There were two major learning curves with development of this model. First, we quickly 
learned that peripheral blood-draws were largely unsuccessful, and found placement of 
tunneled catheters superior. During our initial experience, we removed the tunneled catheters 
on POD 14 after glucose homeostasis testing and replaced them under anesthesia closer to 
final testing and scheduled necropsy. However, following two intra-operative arrests with 
catheter placements, including one in a sham surgery pig, we modified our protocol to allow 
tunneled catheters to remain until necropsy or catheter malfunction. Second, we learned that 
the thick stomach of the Ossabaw was not suitable for standard GIA staplers, and hand-sewn 
anastomoses became our practice.
Our model is limited by a relatively short, 60-day postoperative course, which restricts our 
ability to draw conclusions beyond the study time period or see complications that may 
develop beyond this time window. Furthermore, to date we have only studied a small 
number of Ossabaw in each subgroup, especially RYGB-V. Most of our deaths were early 
during the study period and part of our learning curve for operative technique. Lastly, while 
our preoperative weight, glucose, and insulin values demonstrate increased insulin resistance 
in high-fat-fed Ossabaws vs. lean Ossabaws, these values do not correlate perfectly with 
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human values, and further work is needed to understand how the postoperative changes in GI 
physiology and glucose homeostasis relate to human counterparts.
5. Conclusion
In conclusion, the Ossabaw survival model for metabolic surgery appears to be appropriate, 
reproducible and should offer a novel way to evaluate the mechanism of effect of these 
procedures. This model is being used to evaluate the mechanism of T2DM resolution after 
bariatric surgery, the physiologic impact of novel surgical manipulations of the GI tract, and 
identification of novel targets for surgical and medical interventions.
Acknowledgements
The authors would like to acknowledge Yuki Aoki1 and Kelly Morrisoe1 for their contributions to and coordination 
of perioperative care of the experimental animals. 1Departments of Surgery, University of Washington, Seattle, WA, 
USA.
Funding Disclosures
Research reported in this publication was supported by the by the National Cancer Institute (NCI) under Award 
Number T32CA138312 and the National Institute of Diabetes and Digestive And Kidney Diseases (NIDDK) of the 
National Institutes of Health (NIH) under Award Numbers T32DK070555 and R01DK084324. The content is 
solely the responsibility of the authors and does not necessarily represent the official views of the NCI, NIDDK, or 
NIH.
References
[1]. Sjostrom L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B, et al. Lifestyle, 
Diabetes, and Cardiovascular Risk Factors 10 Years after Bariatric Surgery. New England Journal 
of Medicine. 2004; 351:2683–2693. http://dx.doi.org/10.1056/NEJMoa035622. [PubMed: 
15616203] 
[2]. Sjostrom L, Narbro K, Sjostrom CD, Karason K, Larsson B, Wedel H, et al. Effects of Bariatric 
Surgery on Mortality in Swedish Obese Subjects. New England Journal of Medicine. 2007; 
357:741–752. http://dx.doi.org/10.1056/NEJMoa066254. [PubMed: 17715408] 
[3]. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, et al. Bariatric Surgery: 
A Systematic Review and Meta-Analysis. JAMA. 2004; 292:1724–1737. http://dx.doi.org/
10.1001/jama.292.14.1724. [PubMed: 15479938] 
[4]. Pories WJ, Swanson MS, MacDonald KG, Long SB, Morris PG, Brown BM, et al. Who Would 
Have Thought It? An Operation Proves to Be the Most Effective Therapy for Adult-Onset 
Diabetes Mellitus. Annals of Surgery. 1995; 222:339–350. http://dx.doi.org/
10.1097/00000658-199509000-00011. [PubMed: 7677463] 
[5]. Schauer PR, Burguera B, Ikramuddin S, Cottam D, Gourash W, Hamad G, et al. Effect of 
Laparoscopic Roux-en Y Gastric Bypass on Type 2 Diabetes Mellitus. Annals of Surgery. 2003; 
238:467–484. http://dx.doi.org/10.1097/01.sla.0000089851.41115.1b. [PubMed: 14530719] 
[6]. Thaler JP, Cummings DE. Minireview: Hormonal and Metabolic Mechanisms of Diabetes 
Remission after Gastrointestinal Surgery. Endocrinology. 2009; 150:2518–2525. http://
dx.doi.org/10.1210/en.2009-0367. [PubMed: 19372197] 
[7]. Flum DR, Devlin A, Wright AS, Figueredo E, Alyea E, Hanley PW, et al. Development of a 
Porcine Roux-en-Y Gastric Bypass Survival Model for the Study of Post-Surgical Physiology. 
Obesity Surgery. 2007; 17:1332–1339. http://dx.doi.org/10.1007/s11695-007-9237-5. [PubMed: 
18098400] 
[8]. Varga O, Harangi M, Olsson IA, Hansen AK. Contribution of Animal Models to the 
Understanding of the Metabolic Syndrome: A Systematic Overview. Obesity Reviews. 2010; 
11:792–807. http://dx.doi.org/10.1111/j.1467-789X.2009.00667.x. [PubMed: 19845867] 
Simianu et al. Page 8
Surg Sci. Author manuscript; available in PMC 2016 May 18.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
[9]. Otis CR, Wamhoff BR, Sturek M. Hyperglycemia-Induced Insulin Resistance in Diabetic 
Dyslipidemicyucatan Swine. Comparative Medicine. 2003; 53:53–64. [PubMed: 12625507] 
[10]. Brisbin IL Jr. Mayer JJ. Problem Pigs in a Poke: A Good Pool of Data. Science. 2001; 294:1280–
1281. http://dx.doi.org/10.1126/science.294.5545.1280. [PubMed: 11702791] 
[11]. Martin RJ, Gobble JL, Hartsock TH, Graves HB, Ziegler JH. Characterization of an Obese 
Syndrome in the Pig. Experimental Biology and Medicine. 1973; 143:198–203. http://dx.doi.org/
10.3181/00379727-143-37285. 
[12]. Martin RJ, Herbein JH. A Comparison of the Enzyme Levels and the in Vitro Utilization of 
Various Substrates for Lipogenesis in Pair-Fed Lean and Obese Pigs. Experimental Biology and 
Medicine. 1976; 151:231–235. http://dx.doi.org/10.3181/00379727-151-39180. 
[13]. Wangsness PJ, Martin RJ, Gahagan JH. Insulin and Growth Hormone in Lean and Obese Pigs. 
American Journal of Physiology. 1977; 233:E104–E108. [PubMed: 888946] 
[14]. Edwards JM, Neeb ZP, Alloosh MA, Long X, Bratz IN, Peller CR, et al. Exercise Training 
Decreases Store-Operated Ca2+ Entry Associated with Metabolic Syndrome and Coronary 
Atherosclerosis. Cardiovascular Research. 2010; 85:631–640. http://dx.doi.org/10.1093/cvr/
cvp308. [PubMed: 19744946] 
[15]. Etherton TD, Kris-Etherton PM. Characterization of Plasma Lipoproteins in Swine with Different 
Propensities for Obesity. Lipids. 1980; 15:823–829. http://dx.doi.org/10.1007/BF02534372. 
[PubMed: 7442472] 
[16]. Neeb ZP, Edwards JM, Alloosh M, Long X, Mokelke EA, Sturek M. Metabolic Syndrome and 
Coronary Artery Disease in Ossabaw Compared with Yucatan Swine. Comparative Medicine. 
2010; 60:300–315. [PubMed: 20819380] 
[17]. Dyson MC, Alloosh M, Vuchetich JP, Mokelke EA, Sturek M. Components of Metabolic 
Syndrome and Coronary Artery Disease in Female Ossabaw Swine Fed Excess Atherogenic Diet. 
Comparative Medicine. 2006; 56:35–45. [PubMed: 16521858] 
[18]. Lee L, Alloosh M, Saxena R, Van Alstine W, Watkins BA, Klaunig JE, et al. Nutritional Model of 
Steatohepatitis and Metabolic Syndrome in the Ossabaw Miniature Swine. Hepatology. 2009; 
50:56–67. http://dx.doi.org/10.1002/hep.22904. [PubMed: 19434740] 
[19]. Rao RS, Rao V, Kini S. Animal Models in Bariatric Surgery—A Review of the Surgical 
Techniques and Postsurgical Physiology. Obesity Surgery. 2010; 20:1293–1305. http://dx.doi.org/
10.1007/s11695-010-0135-x. [PubMed: 20383602] 
[20]. National Research Council (US) Committee for the Update of the Guide for the Care and Use of 
Laboratory Animals. Guide for the Care and Use of Laboratory Animals. Eighth Edition. The 
National Academies Press; Washington DC: 2011. 
[21]. AVMA Panel on Euthanasia. 2000 Report of the AVMA Panel on Euthanasia. Journal of the 
American Veterinary Medical Association. 2001; 218:669–696. http://dx.doi.org/10.2460/javma.
2001.218.669. [PubMed: 11280396] 
[22]. Lombardo C, Damiano G, Cassata G, Palumbo VD, Cacciabaudo F, Spinelii G, et al. Surgical 
Vascular Access in the Porcine Model for Long-Term Repeated Blood Sampling. Acta Bio-
Medica. 2010; 81:101–103. [PubMed: 21309130] 
[23]. Harris WH. A Technique for Chronic Venous Cannulation in Swine. Laboratory Animals. 1974; 
8:237–240. http://dx.doi.org/10.1258/002367774781005706. [PubMed: 4831741] 
[24]. Hu C, Cheang A, Retnam L, Yap EH. A Simple Technique for Blood Collection in the Pig. 
Laboratory Animals. 1993; 27:364–367. http://dx.doi.org/10.1258/002367793780745606. 
[PubMed: 8277710] 
[25]. Swindle, MM. Chronic Intravascular Catheterization in Swine: Peripheral Vessels. Sinclair 
Research Institute, Inc.; Columbia: 2004. 
[26]. Swindle, MM. Chronic Intravascular Catheterization in Swine: General Principles. Sinclair 
Research Center, Inc.; Columbia: 2004. 
[27]. Rubino F, Schauer PR, Kaplan LM, Cummings DE. Metabolic Surgery to Treat Type 2 Diabetes: 
Clinical Outcomes and Mechanisms of Action. Annual Review of Medicine. 2010; 61:393–411. 
http://dx.doi.org/10.1146/annurev.med.051308.105148. 
Simianu et al. Page 9
Surg Sci. Author manuscript; available in PMC 2016 May 18.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
[28]. Cummings DE, Overduin J, Foster-Schubert KE, Carlson MJ. Role of the Bypassed Proximal 
Intestine in the Anti-Diabetic Effects of Bariatric Surgery. Surgery for Obesity and Related 
Diseases. 2007; 3:109–115. http://dx.doi.org/10.1016/j.soard.2007.02.003. [PubMed: 17386391] 
[29]. Rubino F, Forgione A, Cummings DE, Vix M, Gnuli D, Mingrone G, et al. The Mechanism of 
Diabetes Control after Gastrointestinal Bypass Surgery Reveals a Role of the Proximal Small 
Intestine in the Pathophysiology of Type 2 Diabetes. Annals of Surgery. 2006; 244:741–749. 
http://dx.doi.org/10.1097/01.sla.0000224726.61448.1b. [PubMed: 17060767] 
[30]. Cummings DE. Gastric Bypass and Nesidioblastosis—Too Much of a Good Thing for Islets? 
New England Journal of Medicine. 2005; 353:300–302. http://dx.doi.org/10.1056/
NEJMe058170. [PubMed: 16034017] 
[31]. Thaler JP, Cummings DE. Metabolism: Food Alert. Nature. 2008; 452:941–942. http://dx.doi.org/
10.1038/452941a. [PubMed: 18432230] 
[32]. Cummings DE, Weigle DS, Frayo RS, Breen PA, Ma MK, Dellinger EP, et al. Plasma Ghrelin 
Levels after Diet-Induced Weight Loss or Gastric Bypass Surgery. New England Journal of 
Medicine. 2002; 346:1623–1630. http://dx.doi.org/10.1056/NEJMoa012908. [PubMed: 
12023994] 
[33]. Cummings DE, Shannon MH. Ghrelin and Gastric Bypass: Is There a Hormonal Contribution to 
Surgical Weight Loss? The Journal of Clinical Endocrinology & Metabolism. 2003; 88:2999–
3002. http://dx.doi.org/10.1210/jc.2003-030705. [PubMed: 12843132] 
[34]. Courcoulas AP, Flum DR. Filling the Gaps in Bariatric Surgical Research. Journal of the 
American Medical Association. 2005; 294:1957–1960. http://dx.doi.org/10.1001/jama.
294.15.1957. [PubMed: 16234502] 
[35]. Arner P. Resistin: Yet Another Adipokine Tells Us That Men Are Not Mice. Diabetologia. 2005; 
48:2203–2205. http://dx.doi.org/10.1007/s00125-005-1956-3. [PubMed: 16193286] 
[36]. Cefalu WT. Animal Models of Type 2 Diabetes: Clinical Presentation and Pathophysiological 
Relevance to the Human Condition. ILAR Journal. 2006; 47:186–198. http://dx.doi.org/10.1093/
ilar.47.3.186. [PubMed: 16804194] 
[37]. Sheikh SP, Holst JJ, Orskov C, Ekman R, Schwartz TW. Release of PYY from Pig Intestinal 
Mucosa; Luminal and Neural Regulation. Regulatory Peptides. 1989; 26:253–266. http://
dx.doi.org/10.1016/0167-0115(89)90193-6. [PubMed: 2623190] 
[38]. Adrian TE, Bacarese-Hamilton AJ, Smith HA, Chohan P, Manolas KJ, Bloom SR. Distribution 
and Postprandial Release of Porcine Peptide YY. Journal of Endocrinology. 1987; 113:11–14. 
http://dx.doi.org/10.1677/joe.0.1130011. [PubMed: 3585220] 
[39]. Hayashida T, Murakami K, Mogi K, Nishihara M, Nakazato M, Mondal MS, et al. Ghrelin in 
Domestic Animals: Distribution in Stomach and Its Possible Role. Domestic Animal 
Endocrinology. 2001; 21:17–24. http://dx.doi.org/10.1016/S0739-7240(01)00104-7. [PubMed: 
11524171] 
[40]. Salfen BE, Carroll JA, Keisler DH. Endocrine Responses to Short-Term Feed Deprivation in 
Weanling Pigs. Journal of Endocrinology. 2003; 178:541–551. http://dx.doi.org/10.1677/joe.
0.1780541. [PubMed: 12967345] 
[41]. Sham JG, Simianu VV, Wright AS, Stewart SD, Alloosh M, Sturek M, Cummings DE, Flum DR. 
Evaluating the Mechanisms of Improved Glucose Homeostasis after Bariatric Surgery in 
Ossabaw Miniature Swine. Journal of Diabetes Research. 2014; 2014 Article ID: 526972. http://
dx.doi.org/10.1155/2014/526972. 
[42]. Berthoud HR. Vagal and Hormonal Gut-Brain Communication: From Satiation to Satisfaction. 
Neurogastroenterology & Motility. 2008; 20:64–72. http://dx.doi.org/10.1111/j.
1365-2982.2008.01104.x. [PubMed: 18402643] 
[43]. Cummings DE, Overduin J. Gastrointestinal Regulation of Food Intake. Journal of Clinical 
Investigation. 2007; 117:13–23. http://dx.doi.org/10.1172/JCI30227. [PubMed: 17200702] 
Simianu et al. Page 10
Surg Sci. Author manuscript; available in PMC 2016 May 18.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 1. 
Weight change following surgery for Obesogenic-diet Ossabawsa,b. aMean change in weight 
reported as percentage (±SD) change from preoperative weigh (Sham: 78.1 ± 15.2 kg; GJ: 
72.3 ± 8.0 kg; GJD: 79.8 ±8.1 kg; RYGB: 68.5 ± 7.0 kg; RYGB-V: 70.7 ± 6.7 kg); bOnly 
pigs surviving beyond immediate postoperative period (POD 35+) included in estimates 
(nSham = 2; nGJ = 9; nGJD = 6; nRYGB = 8; nRYGB-V = 2).
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Figure 2. 
Change in food intake following surgery for Obese Ossabawsa. aOnly pigs surviving beyond 
immediate postoperative period (POD 35+) included in estimates (nSham = 2; nGJ = 9; nGJD 
= 6; nRYGB = 8; nRYGB-V = 2).
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Table 1
Obesogenic-diet Ossabaw survival and complications.
All Sham GJ GJD RYGB RYGB-V
N a 32 2
10
(9 to OR) 7 8
5
(4 to OR)
N completing protocol/
N having GI surgery 23/30 1/2 8/9 6/7 6/8 1/2
(%) 77% 50% 89% 86% 75% 50%
Mean Postoperative
survival, days 56.5 68.5 59.8 57.8 61.2 34
Death 9
Intraoperative or
immediate
postoperative
5 1 2 0 2
During catheter
placement 3
1 cardiac arrest
during catheter
replacement,
POD 75
1 cardiac arrest
during initial catheter
placement
1 respiratory arrest
during catheter
replacement,
POD 57
During GI surgery 1
1 cardiac arrest
during initial
surgery
During re-exploration 1
1 explored for leak
POD7, died of
intra-operative
hemorrhage
Death prior to
completion of
study period
4 1 died POD 5,pancreatitis
1 euthanized for
eviceration on
POD 35
1 euthanized for
prolonged difficult
recovery and
decreased PO intake
on POD111 died POD 63,presumed C. diff
a
Pigs expiring of cardiac arrest during initial catheter placement (n = 2) not counted beyond first row as they did not undergo GI surgery.
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